These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10652981)

  • 1. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks.
    Farley TM; Meirik O; Collins J
    Hum Reprod Update; 1999; 5(6):721-35. PubMed ID: 10652981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined oral contraceptives, smoking, and cardiovascular risk.
    Farley TM; Meirik O; Chang CL; Poulter NR
    J Epidemiol Community Health; 1998 Dec; 52(12):775-85. PubMed ID: 10396518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern oral contraceptives and cardiovascular disease.
    Rosenberg L; Palmer JR; Sands MI; Grimes D; Bergman U; Daling J; Mills A
    Am J Obstet Gynecol; 1997 Sep; 177(3):707-15. PubMed ID: 9322646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):505-10. PubMed ID: 8757152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec; 346(8990):1582-8. PubMed ID: 7500749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
    Spitzer WO
    Br J Clin Pharmacol; 1996 May; 41(5):359-63. PubMed ID: 8735675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
    Schwingl PJ; Shelton J
    Contraception; 1997 Mar; 55(3):125-9. PubMed ID: 9114999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular events associated with different combined oral contraceptives: a review of current data.
    Hannaford P
    Drug Saf; 2000 May; 22(5):361-71. PubMed ID: 10830253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal contraception and risk of cardiovascular disease. An international perspective.
    Farley TM; Collins J; Schlesselman JJ
    Contraception; 1998 Mar; 57(3):211-30. PubMed ID: 9617537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.
    van Lunsen HW
    Eur J Contracept Reprod Health Care; 1996; 1(1):39-45. PubMed ID: 9678136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and vascular disease.
    Sartwell PE; Stolley PD
    Epidemiol Rev; 1982; 4():95-109. PubMed ID: 6754411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 1995 pill scare revisited: anatomy of a non-epidemic.
    Spitzer WO
    Hum Reprod; 1997 Nov; 12(11):2347-57. PubMed ID: 9436662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinician's response to the oral contraceptive thrombosis controversy.
    Speroff L
    Hum Reprod Update; 1999; 5(6):654-63. PubMed ID: 10652975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.